nse,bse,nseindia,nse india,share price,stock price,stock value,shares prices,share prices,stock quote,stock prices, share prices, corporate announcements,board meetings,corporate actions,dividends,agm,stock split,bonus

Abbott India Limited (NSE India Code : ABBOTINDIA) SELL

Company Name :

Enter Company Name or NSE Code

ABBOTINDIA Technical Levels

Resistance 2		1627.28
Resistance 1		1615.57
PIVOT		1601.28
Support 1		1589.57
Support 2		1563.57

ABBOTINDIA Fundamentals

Earning Growth		%
Profit Margin
PE
EPS
Quarter

ABBOTINDIA Futures

Close
Contracts Traded
Open Interest(OI)
Change in OI
Lot Size

ABBOTINDIA Options

Most Active Call
Most Active Put
Highest OI Call
Highest OI Put
Expiry Date

ABBOTINDIA Technical Levels

Other Stocks from Pharmaceuticals Sector AARTIDRUGS ABBOTINDIA AJANTPHARM ALCHEM ALKALI ALPA AMRUTANJAN ANKURDRUGS ARL ASTRAZEN AUROPHARMA AVENTIS BALPHARMA BIOCON BLISSGVS CADILAHC CELESTIAL CIPLA DISHMAN DIVISLAB DRREDDY ELDERPHARM FDC FKONCO GLAXO GLENMARK GRANULES INDOCO INDSWFTLAB INDSWFTLTD IPCALAB JAGSNPHARM JBCHEPHARM JUBILANT KILITCH KOPRAN LUPIN LYKALABS MANGALAM MERCK MOREPENLAB NATCOPHARM NECLIFE NEULANDLAB OPTOCIRCUI ORCHIDCHEM PANACEABIO PARABDRUGS PFIZER PIRHEALTH

Sponsored Advertisement

ABBOTINDIA Share Price on 5-10-2012

Open		1597.6
High		1597.6
Low		1565.25
Close		1581.15
Volume		1925
Change		-18.05 (-1.13%)

Series		EQ
Date of Listing		08-Jan-10
Paid Up Value		10
Face Value		10
Market Capital		0 Crores
52 Week High/Low		1789 / 1345.45

Sponsored Advertisement

Abbott India Limited Company Profile

form). Majority of the company`s revenues come from insulin and formulation sales. Other products like Brufen and Digene pertain to their respective therapeutic segments. The company`s product portfolio provides therapies for both acute and chronic health conditions. It is engaged in pharmaceutical formulations including tablets, liquids, injectibles and capsules, and nutritional products including powder. The installed capacity for tablets is 450 million, while for liquids it is 5,185 Kilo liter, and for capsules 46 million. Powder has an installed capacity of 600 tons. However, the company produced 25 million tablets, 1,141 kilo liters of liquids and 29 million capsules. It is the company`s strategy to continue to focus on its core therapeutic areas in pharmaceuticals, viz, CNS, gastroenterology, metabolics, pain management, urology, specialized anesthesia range and neonatology. Growth in chronic therapy areas is expected to continue while innovations and life cycle management will continue to support performance of the company in acute therapy segments. The performance of Abbott India is in line with trends observed in the market, viz., good growth in chronic disease areas. However, the volumes in acute therapy areas such as gastroenterology and pain management continue to be under pressure. The company plans to augment its R&D activities by focusing on new product development, improvement in the present formulations/process and improving operational efficiencies. The company now employs approximately 65,000 people and markets its products in 130 countries worldwide. Abbott India has a network of 18 distribution points, which cater to 11,000 stockists and 70,000 retailers. Financials Abbott India registered a 34.66% growth in net profit to Rs 183 million for the quarter ended May 2007 from a profit of Rs 135.9 million for the quarter ended May 2006. Net sales rose 18.8% to Rs 1,540.4 million for the quarter ended May 2007 from Rs 1,296.6 million for the quarter ended May 2006. Total income rose 20.19% to Rs 1,618.7 million for the quarter ended May 2007 from Rs 1,346.8 million for the quarter ended May 2006. The earnings per share (EPS) of the company stood at Rs 12.65 for the quarter ended May 2007.

ABBOTINDIA Intraday Realtime Chart

ABBOTINDIA Corporate Announcements

DATE

PURPOSE

ABBOTINDIA Corporate Actions

DATE	PURPOSE
04-May-12	Annual General Meeting And Dividend Rs.17/- Per Share
04-May-12	AGM/DIV-RS.17 PER SHARE
19-Apr-11	Annual General Meeting / Final Dividend - Rs.17/- Per Share
19-Apr-11	AGM/DIV-RS.17/- PER SHARE

ABBOTINDIA Board Meetings

MEETING DATE

PURPOSE

ABBOTINDIA Related companies

Symbol	Company Name
AARTIDRUGS	Aarti Drugs Limited
ABBOTINDIA	Abbott India Limited
AJANTPHARM	Ajanta Pharma Limited
ALCHEM	Alchemist Limited
ALKALI	Alkali Metals Limited

Most Active NSE INDIA Stocks

HDFC LITL IVRCLINFRA HDIL UNITECH JPASSOCIAT GVKPIL TATAMOTORS IFCI IBREALEST ESSAROIL GMRINFRA BIRLAPOWER HINDALCO BHEL RENUKA RCOM DLF SUZLON RELCAPITAL IDFC ADANIENT ITC TATAPOWER BALLARPUR

Free Stock Market Tips:

What are Currency Futures?

Home	Stock Market	IPO	Mutual Funds	Education	Paid Service
About us	Share Market	IPO Watch	MF News	IPO	Subscription
VJonDalalStreet	Technical Analysis	New IPO Review	Old Funds	Articles	Equity Performance
DalalStreet Blog	Stock Market News	Indian IPO News	New Funds	Stock Market	Futures Performance
Free Sms Alerts	World Stock Market	IPO Allotment Status	Best Funds	Financial Terms	Options Performance
Privacy	Stock Recommendations	Grey Market Premium	MF Analysis	Futures & Options	Jackpot Performance

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither VJonDalalStreet.com website nor any of its promoters shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes acceptance of our Disclaimer